Annual Current Liabilities
$7.19 M
-$4.91 M-40.57%
December 31, 2023
Summary
- As of February 8, 2025, OCX annual total current liabilities is $7.19 million, with the most recent change of -$4.91 million (-40.57%) on December 31, 2023.
- During the last 3 years, OCX annual current liabilities has fallen by -$1.80 million (-20.03%).
- OCX annual current liabilities is now -49.05% below its all-time high of $14.12 million, reached on December 31, 2021.
Performance
OCX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$9.09 M
+$1.89 M+26.29%
September 30, 2024
Summary
- As of February 8, 2025, OCX quarterly total current liabilities is $9.09 million, with the most recent change of +$1.89 million (+26.29%) on September 30, 2024.
- Over the past year, OCX quarterly current liabilities has increased by +$1.06 million (+13.16%).
- OCX quarterly current liabilities is now -54.03% below its all-time high of $19.77 million, reached on June 30, 2021.
Performance
OCX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
OCX Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -40.6% | +13.2% |
| 3 y3 years | -20.0% | -35.8% |
| 5 y5 years | +29.4% | -35.8% |
OCX Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -49.0% | at low | -35.8% | +26.4% |
| 5 y | 5-year | -49.0% | +62.0% | -54.0% | +104.7% |
| alltime | all time | -49.0% | +210.9% | -54.0% | +342.1% |
OncoCyte Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $9.09 M(+26.3%) |
| Jun 2024 | - | $7.20 M(-13.6%) |
| Mar 2024 | - | $8.33 M(+15.7%) |
| Dec 2023 | $7.19 M(-40.6%) | $7.19 M(-10.4%) |
| Sep 2023 | - | $8.03 M(+4.8%) |
| Jun 2023 | - | $7.67 M(-18.7%) |
| Mar 2023 | - | $9.43 M(-22.1%) |
| Dec 2022 | $12.11 M(-14.3%) | $12.11 M(-6.5%) |
| Sep 2022 | - | $12.95 M(-8.5%) |
| Jun 2022 | - | $14.15 M(+1.4%) |
| Mar 2022 | - | $13.96 M(-1.2%) |
| Dec 2021 | $14.12 M(+57.0%) | $14.12 M(+5.6%) |
| Sep 2021 | - | $13.38 M(-32.4%) |
| Jun 2021 | - | $19.77 M(+104.2%) |
| Mar 2021 | - | $9.69 M(+7.7%) |
| Dec 2020 | $9.00 M(+102.6%) | $9.00 M(+1.1%) |
| Sep 2020 | - | $8.90 M(+30.0%) |
| Jun 2020 | - | $6.84 M(-1.2%) |
| Mar 2020 | - | $6.93 M(+56.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $4.44 M(-20.2%) | $4.44 M(+45.9%) |
| Sep 2019 | - | $3.04 M(-25.1%) |
| Jun 2019 | - | $4.06 M(+27.0%) |
| Mar 2019 | - | $3.20 M(-42.5%) |
| Dec 2018 | $5.56 M(+24.9%) | $5.56 M(+20.4%) |
| Sep 2018 | - | $4.62 M(+3.0%) |
| Jun 2018 | - | $4.49 M(-18.0%) |
| Mar 2018 | - | $5.47 M(+22.7%) |
| Dec 2017 | $4.45 M(+4.2%) | $4.45 M(-3.9%) |
| Sep 2017 | - | $4.64 M(-1.0%) |
| Jun 2017 | - | $4.69 M(+3.0%) |
| Mar 2017 | - | $4.55 M(+6.4%) |
| Dec 2016 | $4.28 M(+84.7%) | $4.28 M(+7.7%) |
| Sep 2016 | - | $3.97 M(+46.3%) |
| Jun 2016 | - | $2.71 M(-1.4%) |
| Mar 2016 | - | $2.75 M(+18.9%) |
| Dec 2015 | $2.31 M(-63.4%) | $2.31 M(+12.5%) |
| Sep 2015 | - | $2.06 M(-67.4%) |
| Dec 2014 | $6.32 M(+35.2%) | $6.32 M |
| Dec 2013 | $4.67 M | - |
FAQ
- What is OncoCyte annual total current liabilities?
- What is the all time high annual current liabilities for OncoCyte?
- What is OncoCyte annual current liabilities year-on-year change?
- What is OncoCyte quarterly total current liabilities?
- What is the all time high quarterly current liabilities for OncoCyte?
- What is OncoCyte quarterly current liabilities year-on-year change?
What is OncoCyte annual total current liabilities?
The current annual current liabilities of OCX is $7.19 M
What is the all time high annual current liabilities for OncoCyte?
OncoCyte all-time high annual total current liabilities is $14.12 M
What is OncoCyte annual current liabilities year-on-year change?
Over the past year, OCX annual total current liabilities has changed by -$4.91 M (-40.57%)
What is OncoCyte quarterly total current liabilities?
The current quarterly current liabilities of OCX is $9.09 M
What is the all time high quarterly current liabilities for OncoCyte?
OncoCyte all-time high quarterly total current liabilities is $19.77 M
What is OncoCyte quarterly current liabilities year-on-year change?
Over the past year, OCX quarterly total current liabilities has changed by +$1.06 M (+13.16%)